Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
Homecas120014-06-4

120014-06-4

120014-06-4 structural image
Product Name: Donepezil
Formula: C24H29NO3
Inquiry

CHEMICAL AND PHYSICAL PROPERTIES

Physical Description Solid
Boiling Point 527.9
Melting Point 223-227
Solubility 31mg/mL
LogP 4.7
Dissociation Constants 9.08
Collision Cross Section 198.1 Ų [M+H]+ [CCS Type: TW, Method: Major Mix IMS/Tof Calibration Kit (Waters)]
Other Experimental Properties Crystals from methanol/IPE; mw 415.95; mp 211-212 °C (decomposes) /Donepezil hydrochloride/

SAFETY INFORMATION

Signal word Warning
Pictogram(s)

Exclamation Mark
Irritant
GHS07
GHS Hazard Statements H315:Skin corrosion/irritation
H319:Serious eye damage/eye irritation
H335:Specific target organ toxicity, single exposure;Respiratory tract irritation
Precautionary Statement Codes P261:Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

COMPUTED DESCRIPTORS

Molecular Weight 379.5 g/mol
XLogP3 4.3
Hydrogen Bond Donor Count 0
Hydrogen Bond Acceptor Count 4
Rotatable Bond Count 6
Exact Mass 379.21474379 g/mol
Monoisotopic Mass 379.21474379 g/mol
Topological Polar Surface Area 38.8 Ų
Heavy Atom Count 28
Formal Charge 0
Complexity 510
Isotope Atom Count 0
Defined Atom Stereocenter Count 0
Undefined Atom Stereocenter Count 1
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
Covalently-Bonded Unit Count 1
Compound Is Canonicalized Yes

PRODUCT INTRODUCTION

description

Donepezil is a racemate comprising equimolar amounts of (R)- and (S)-donepezil. A centrally acting reversible acetylcholinesterase inhibitor, its main therapeutic use is in the treatment of Alzheimer's disease where it is used to increase cortical acetylcholine. It has a role as an EC 3.1.1.7 (acetylcholinesterase) inhibitor, a nootropic agent and an EC 3.1.1.8 (cholinesterase) inhibitor. It contains a (R)-donepezil and a (S)-donepezil. It is a conjugate base of a donepezil (1+).

RELATED SUPPLIERS

Cadila Pharmaceuticals Ltd

1Y
product:120014-06-4 Donepezil 99%

J S LABS

1Y
product:120014-06-4 98%

Gonane Pharma

1Y
product:Donepezil HCL / Base 99%

NEULAND LABS

1Y
product:Donepezil 98%

Zydus Lifesciences Ltd.

1Y
product:120014-06-4 Donepezil 98%

Besil Chem LLP

1Y
product:120014-06-4 98%

Ebenezer Industries

product:Donepezil 98%

Ralington Pharma

1Y
product:Donepezil 98%

Alfa Omega Pharma

1Y
product:Donepezil 120014-06-4 98%
All suppliers(12)